Comparison
AxonQA vs Xray
Xray is native test management for Jira, with AI that drafts test cases and automation scripts from your test context. AxonQA is for teams who want the rest of the loop connected: running those tests, keeping them working, and turning the results into an answer on whether the release is safe.
14-day trialNo card requiredSample project included
The short answer
Xray is the strongest option if you want testing to live inside Jira. Tests are Jira issues, traceability is native rather than integrated, BDD is first class, and its AI drafts cases and scripts from your test context. Check its deployment and AI terms against your data-handling requirements.
What Xray hands you is well-organised artifacts and traceability. Somebody still has to run the automation, fix it when the interface changes, and decide what the results mean on release day.
AxonQA covers that end. It runs the tests, repairs the ones that broke because something moved, keeps the API checks and the bugs in the same project, and evaluates all of it against conditions your team set in advance.
Side by side
What each one does
Written to be checked. Two rows here go to Xray, and they say so.
| Capability | Xray | AxonQA |
|---|---|---|
| Where it lives | Native to Jira. Tests are Jira issues, with everything in one place. | A separate workspace that imports from Jira and Azure DevOps, and files bugs back. |
| Requirement traceability | Strong, and native. Tests link to requirements as Jira issues. | Requirements imported and linked to the tests that cover them. |
| BDD, Gherkin and Cucumber | First class, and a core reason teams pick Xray. | Not our strength. Structured cases and generated automation instead. |
| AI test case generation | Yes. Drafts cases from written requirements, with review before they are created. | Yes. From requirements, or from the application itself. |
| AI automation script generation | Yes, on Advanced and Enterprise. Scripts from manual tests. | Yes, as structured, maintainable automation. |
| Where the AI processing happens | Review the AI terms for your deployment. Xray Cloud uses Forge Remote with an external backend; a Jira interface alone does not establish data residency. | Relevant inputs reach commercial AI providers after text scrubbing and local image redaction, with detection limits. Customer content is not used for model training. |
| How far the AI reaches | Its published AI capabilities generate test cases and automation scripts inside Jira. | Axon can organise work, create and run UI and API checks, investigate failures, update trackers, and report back from one conversation. |
| Running the automation | Results are reported back from your own pipeline. | Runs it. Cloud, or a local agent for private applications. |
| Repairing tests when the interface moves | Not described in the linked AI material; confirm with Xray. | Repairs locator drift while the run is still going, and never changes what the test expects. |
| API testing in the same workspace | Not described in the linked AI material; confirm with Xray. | Built in, alongside the UI tests and counted in the same coverage. |
| Exploring the app to find what to test | Not described in the linked AI material; confirm with Xray. | Optional. Walks the app and drafts cases from what it finds. |
| A release verdict from connected evidence | Coverage and reports inside Jira, which you interpret yourself. | Evaluates conditions matched to the release scope against bars you set and returns one of three verdicts. |
The difference that matters
Traceability tells you what was covered. It does not tell you whether to ship.
Xray is very good at the question “which requirements have tests?”. That is a real question and native Jira traceability answers it better than a bolt-on ever will.
Release day asks a different question. Not what is covered, but what the last run actually did: which tests failed and whether that was the interface moving or the product breaking, which API checks passed, which bugs are still open and at what severity, whether every manual phase finished, and whether any of that breaches the rules your team agreed before the sprint started.
AxonQA can answer that because it owns each of those inputs rather than reading a report about them. Conditions matched to the release scope, each against a bar you set, resolving to one of three outcomes: ready, ready with things you are knowingly accepting, or not ready. The record is frozen at the decision, so it still stands up when someone asks a month later.
Which one is for you
There is a real answer here, and it is not always us
If Jira is where your team works and Xray is working, moving costs you something. Weigh it honestly.
Choose Xray if
- You want test management native to Jira, where a test is a Jira issue and traceability comes for free.
- BDD, Gherkin and Cucumber are central to how your team writes tests.
- You want Jira-native test management and have reviewed Xray’s deployment and AI data terms for your security requirements.
- Your automation already runs reliably in your own pipeline, and reporting results back into Jira is enough.
- You need an established Atlassian Marketplace vendor with enterprise procurement history and certifications.
Choose AxonQA if
- Your evidence is spread across a test management tool, a CI pipeline, an API client and a bug tracker, and nothing joins it up.
- You want generated automation that also runs, and repairs itself when the interface changes.
- You want API checks and manual passes counted in the same coverage number.
- You need to answer “can we ship” against conditions agreed in advance, and defend that answer a month later.
Built to sit alongside Jira.
Epics and stories come in from Jira, and tests link to the work items they cover, so coverage is measured against the requirements your team already wrote. Bugs from failed runs are filed straight back with the reproduction steps and the recording attached, and their status syncs as your team works them. Your team plans where it already plans. What changes is that the QA evidence stops living in a spreadsheet beside the tracker.
Current controls include encryption, organisation isolation, role-based access, two-factor authentication, restricted artifact access, audit logs and tested backup restoration. An ISO 27001-aligned information security management system is operating, with documented control mappings and owned risks. We do not hold ISO 27001 certification or a SOC 2 report, and SSO is not yet available. The security overview records the evidence and remaining work for your review.
Comparing other tools? See all comparisons
See a verdict on your own project.
Start a trial, import from Jira, and get an answer you can put in front of a stakeholder.
14-day trial · No card required · Sample project included